Insulin-degrading enzyme in the Alzheimer's disease brain: Prominent localization in neurons and senile plaques

Neuroscience Letters

Volumn 263, Issue 2-3, 1999, Pages 161-164

  Bernstein, Hans Gert ^a   Ansorge, Siegfried ^a   Riederer, Peter ^b   Reiser, Michael ^a   Frölich, Lutz ^c   Bogerts, Bernhard ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Alzheimer disease; Amyloid beta protein; Human brain; Insulin degrading enzyme

Indexed keywords

AMYLOID; INSULINASE; POLYCLONAL ANTIBODY;

ALZHEIMER DISEASE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LOCALIZATION; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LEWY BODY; NERVE CELL; OLIVARY NUCLEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SENILE PLAQUE; TISSUE DISTRIBUTION;

ADULT; AGED; ALZHEIMER DISEASE; BRAIN; FEMALE; HUMANS; INSULYSIN; MALE; NEURITES; NEURONS; PYRAMIDAL CELLS; SENILE PLAQUES;

EID: 0033605607     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00135-4     Document Type: Article

References (22)

1. Ansorge S., Bohley P., Kirschke H., Langner J., Wiederanders B. The insulin and glucagon degrading proteinase of rat liver: a metal-dependent enzyme. Biomed. Biochim. Acta. 43:1984;39-46.
2. Authier F. Insulin-degrading enzyme. Clin. Invest. Med. 19:1996;149-160.
3. Azam M., Gupta B.L., Gupta G., Jain S., Baquer N.Z. Rat brain insulin degrading enzyme in insulin and thyroid hormones imbalances. Biochem. Int. 21:1990;321-329.
4. Bernstein H.-G., Müller M. Increased immunostaining for L-ornithine decarboxylase occurs in neocortical neurons of Alzheimer's disease patients. Neurosci. Lett. 186:1995;123-126.
5. Bernstein H.-G., Stanarius A., Baumann B., Henning H., Krell D., Danos D., Falkai P., Bogerts B. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience. 83:1998;867-875.
6. Dorn A., Bernstein H.-G., Rinne A., Ziegler M., Hahn H.-J., Ansorge S. Insulin-and glucagonlike peptides in the brain. Anat. Rec. 207:1983;69-77.
7. Dorn A., Bernstein H.-G., Reiser M., Rinne A., Ansorge A. Degradation of insulin and glucagon in developing rat kidney: immunolocalization of insulin-glucagon specific protease and quantitative estimation. J. Histochem. Cytochem. 34:1986;411-412.
8. Forstl H., Burns A., Luthert P., Cairns N., Levy R. The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings. Br. J. Psychiatry. 162:1993;385-392.
9. Frölich L., Blum-Degen D., Bernstein H.-G., Engelsberger S., Humrich J., Laufer S., Thalheimer A., Türk A., Hoyer S., Zöchling R., Boissl K.W., Jellinger K., Riederer P. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J. Neural Transm. 105:1998;423-438.
10. Hamel F.G., Bennett R.G., Duckworth W.C. Regulation of multicatalytic enzyme activity by insulin and the insulin-degrading enzyme. Endocrinology. 129:1998;4061-4066.
11. Kurochkin I.V. Amyloidogenic determinant as a substrate recognition site motif of insulin-degrading enzyme. FEBS Lett. 427:1998;153-156.
12. Kurochkin I.V., Goto S. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 345:1994;33-37.
13. McDermott J.R., Gibson A.M. Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme. Neurochem. Res. 22:1997;49-56.
14. Morimura Y., Hirano A., Llena J.F. Electron-microscopic observation of the nucleus basalis of Meynert in human autopsy cases. Acta Neuropathol. 68:1985;130-137.
15. Müller D., Baumeister H., Buck F., Richter D. Atrial natriuretic peptide (ANP) is a highly affinity substrate for rat brain insulin-degrading enzyme. Eur. J. Biochem. 202:1991;285-292.
16. Perez, A.A., Morelli, L., Cresto, J.C. and Castano, E.M., Alzheimer amyloids Aβ1-40 and Aβ1-42 are differentially degraded by insulin-degrading enzyme (IDE) from human brain, Soc. Neurosci. Abstr., 321.13 (1997) 821.
17. Qiu W.Q., Walsh D.M., Ye Z., Vekrellis K., Zhang J., Podlisny M.B., Rosner M.R., Safavi A., Hersh L.B., Selkoe D.J. Insulin-degrading enzyme regulates extracellular levels od amyloid beta-protein by degradation. J. Biol. Chem. 273:1998;32730-32738.
18. Reiser M., Bernstein H.-G., Ansorge S., Dorn A. Proteolytic degradation of insulin and glucagon in rat brain during ontogenesis. Acta Histochem. 82:1987;35-39.
19. Roth R.A., Mesirow M.L., Yokono K., Baba S. Degradation of insulin-like growth factors I and II by a human insulin-degrading enzyme. Endocr. Res. 10:1984;101-112.
20. Safavi A., Miller B.C., Cottam L., Hersh L.B. Identification of gamma-endorphin-generating enzyme as insulin-degrading enzyme. Biochemistry. 35:1996;14318-14325.
21. Takeda A., Hashimoto M., Mallory M., Sundsumo M., Hansen L., Sisk A., Masliah E. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy boy disease as revealed by proteinase K and formic acid pretreatment. Lab. Invest. 78:1998;1169-1177.
22. Vekrellis, K., Qiu, W.Q., Ye, Z., Sperling, R. and Selkoe, D.J., Implication of insulin-degrading enzyme in the degradation and oligomerization of amyloid β-protein, Soc. Neurosci. Abstr. 84.4 (1998) 207.